|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$49,664,092 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$49,664,092 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-38.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2013-08-16 |
4 |
S |
$42.85 |
$428,500 |
D/D |
(10,000) |
110,025 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2015-06-09 |
4 |
S |
$92.53 |
$928,809 |
D/D |
(10,000) |
126,044 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2015-08-06 |
4 |
S |
$110.79 |
$516,946 |
D/D |
(4,666) |
121,378 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-03-07 |
4 |
S |
$102.44 |
$1,110,027 |
D/D |
(10,833) |
119,664 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2016-09-08 |
4 |
S |
$109.83 |
$186,716 |
D/D |
(1,700) |
1,359 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-09-22 |
4 |
S |
$117.34 |
$352,020 |
D/D |
(3,000) |
122,664 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
S |
$107.06 |
$428,240 |
D/D |
(4,000) |
128,969 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-11-16 |
4 |
S |
$142.53 |
$750,991 |
D/D |
(5,269) |
143,542 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-11-17 |
4 |
S |
$140.34 |
$316,888 |
D/D |
(2,258) |
141,284 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2018-08-23 |
4 |
S |
$187.92 |
$1,879,173 |
D/D |
(10,000) |
3,012 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-08-30 |
4 |
S |
$258.25 |
$903,875 |
D/D |
(3,500) |
85,419 |
0 |
- |
|
TECH |
Techne Corp |
|
|
2019-06-04 |
4 |
S |
$203.67 |
$1,018,346 |
D/D |
(5,000) |
3,526 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2020-02-12 |
4 |
S |
$205.23 |
$1,026,133 |
D/D |
(5,000) |
4,021 |
0 |
% |
|
TECH |
Techne Corp |
|
|
2020-11-06 |
4 |
S |
$298.98 |
$1,501,744 |
D/D |
(5,000) |
4,412 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-11-12 |
4 |
S |
$160.50 |
$481,500 |
D/D |
(3,000) |
335,095 |
0 |
% |
|
TECH |
Techne Corp |
Director |
|
2022-08-10 |
4 |
S |
$373.99 |
$751,194 |
D/D |
(1,992) |
6,014 |
0 |
% |
|
TECH |
Techne Corp |
Director |
|
2022-08-11 |
4 |
S |
$380.71 |
$197,322 |
D/D |
(512) |
5,502 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-15 |
4 |
S |
$90.00 |
$180,000 |
D/D |
(2,000) |
367,180 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4 |
S |
$89.35 |
$268,050 |
D/D |
(3,000) |
364,180 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4/A |
S |
$88.06 |
$88,060 |
D/D |
(1,000) |
366,180 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-18 |
4 |
S |
$3.89 |
$194,500 |
D/D |
(50,000) |
2,462,686 |
0 |
% |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-19 |
4 |
S |
$4.05 |
$4,050 |
D/D |
(1,000) |
2,462,686 |
0 |
% |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-23 |
4 |
S |
$4.05 |
$36,450 |
D/D |
(9,000) |
2,462,686 |
0 |
% |
|
TECH |
Techne Corp |
Director |
|
2024-05-14 |
4 |
S |
$83.84 |
$335,377 |
D/D |
(4,000) |
36,608 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2013-08-19 |
4 |
OE |
$16.14 |
$105,814 |
D/D |
6,556 |
116,581 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|